Tsukuba, Japan

Naoki Sano

This inventor holds 1 USPTO granted patent. Top assignees: Kewpie Corporation, University of Tsukuba. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Sano. Retrieved from https://idiyas.com/inventor/naoki-sano-diph2nsj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoki Sano: Innovator in Hepatic Medicine

Introduction

Naoki Sano is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medicine, particularly in the area of hepatic disorders. His innovative work has the potential to impact the treatment of liver-related conditions.

Latest Patents

Naoki Sano holds a patent for "Hyaluronic acid modified by sphingosine-1-phosphoric acid." This invention involves hyaluronic acid modified with sphingosine-1-phosphate, which serves as an active ingredient in a medicine designed to alleviate hepatic disorders caused by hypoxia/reoxygenation. The medicine aims to protect liver sinusoidal endothelial cells and can prevent or treat liver failure due to liver transplantation, hepatectomy, or other surgeries associated with liver ischemia/reperfusion. He has 1 patent to his name.

Career Highlights

Throughout his career, Naoki Sano has worked with notable organizations, including Kewpie Corporation and the University of Tsukuba. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Naoki has collaborated with esteemed colleagues such as Hideyoshi Harashima and Mamoru Hyodo. Their joint efforts have contributed to advancements in research and development in hepatic medicine.

Conclusion

Naoki Sano's work exemplifies the intersection of innovation and medicine, particularly in addressing liver health issues. His contributions are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…